NASHP

Prescription Drug Pricing Transparency Law Comparison Chart

Updated July 2, 2021

A number of states have enacted drug pricing transparency laws requiring drug supply chain entities such as manufacturers, pharmacy benefit managers, health plans, and others to report information explaining high price increases and high-priced new drugs. This chart compares states’ transparency laws, each tab provides an overview of required reporting from specific supply chain entities. To learn more about how states are implementing transparency laws and reporting on high drug prices, explore the Center for State Rx Drug Pricing’s Administrative Action tracker.

Copyright © 2019, by The National Academy for State Health Policy. All rights reserved. May not be published or otherwise distributed without explicit permission | Privacy Policy | Terms Of Use